blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2674440

EP2674440 - MULTIVALENT IMMUNOGLOBULIN-BASED BIOACTIVE ASSEMBLIES [Right-click to bookmark this link]
Former [2013/51]Multivalent immunoglobulin-based bioactive assemblies
[2019/04]
StatusNo opposition filed within time limit
Status updated on  03.07.2020
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  31.05.2019
FormerGrant of patent is intended
Status updated on  07.01.2019
FormerExamination is in progress
Status updated on  18.01.2017
Most recent event   Tooltip09.07.2021Lapse of the patent in a contracting state
New state(s): HU		published on 11.08.2021  [2021/32]
Applicant(s)For all designated states
IBC Pharmaceuticals, Inc.
300 American Road
Morris Plains, NJ 07950 / US
[2013/51]
Inventor(s)01 / Chang, Chien-Hsing
c/o IBC Pharmaceuticals, Inc.
300 American Road
Morris Plains, NJ 07950 / US
02 / Goldenberg, David
c/o IBC Pharmaceuticals, Inc.
300 American Road
Morris Plains, NJ 07950 / US
03 / Rossi, Edmund
c/o IBC Pharmaceuticals, Inc.
300 American Road
Morris Plains, NJ 07950 / US
 [2013/51]
Representative(s)Bohmann, Armin K.
Bohmann
Anwaltssozietät
Nymphenburger Straße 1
80335 München / DE
[2019/27]
Former [2013/51]Bohmann, Armin K.
bohmann Anwaltssozietät Nymphenburger Strasse 1
80335 München / DE
Application number, filing date13004490.205.12.2006
[2013/51]
Priority number, dateUS20050751196P16.12.2005         Original published format: US 751196 P
US20060782332P14.03.2006         Original published format: US 782332 P
WO2006US1076224.03.2006         Original published format: PCT/US2006/010762
US2006038935824.03.2006         Original published format: US 389358
US2006039158428.03.2006         Original published format: US 391584
WO2006US1208429.03.2006         Original published format: PCT/US2006/012084
WO2006US2549929.06.2006         Original published format: PCT/US2006/025499
US2006047802129.06.2006         Original published format: US 478021
US20060864530P06.11.2006         Original published format: US 864530 P
[2013/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2674440
Date:18.12.2013
Language:EN
[2013/51]
Type: A3 Search report 
No.:EP2674440
Date:05.03.2014
Language:EN
[2014/10]
Type: B1 Patent specification 
No.:EP2674440
Date:03.07.2019
Language:EN
[2019/27]
Search report(s)(Supplementary) European search report - dispatched on:EP04.02.2014
ClassificationIPC:C07K16/46, A61K39/395, A61K38/17, A61K48/00, C07K16/00, A61K47/68, C07K16/30, A61K39/00
[2019/04]
CPC:
C07K16/468 (EP); A61K47/6853 (EP); A61K47/6879 (EP);
C07K16/00 (EP); C07K16/3007 (EP); A61K2039/505 (EP);
C07K2317/55 (EP); C07K2317/624 (EP); C07K2319/00 (EP);
C07K2319/70 (EP) (-)
Former IPC [2014/10]C07K16/46, A61K39/395, A61K38/17, A61K48/00, C07K16/00, A61K47/48, C07K16/30, A61K39/00
Former IPC [2013/51]C07K16/46, A61K39/395, A61K38/17, A61K48/00, C07K16/00, A61K47/48, C07K16/30
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/51]
TitleGerman:POLYVALENTE BIOAKTIVE ANORDNUNGEN AUF IMMUNGLOBULINBASIS[2019/04]
English:MULTIVALENT IMMUNOGLOBULIN-BASED BIOACTIVE ASSEMBLIES[2019/04]
French:ENSEMBLES BIOACTIFS À BASE D'IMMUNOGLOBULINE MULTIVALENT[2019/04]
Former [2013/51]Polyvalente bioaktive Anordnungen auf Immunglobulinbasis
Former [2013/51]Multivalent immunoglobulin-based bioactive assemblies
Former [2013/51]Ensembles bioactifs à base d'immunoglobuline multivalent
Examination procedure13.09.2013Examination requested  [2013/51]
14.10.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
05.01.2015Amendment by applicant (claims and/or description)
10.03.2016Despatch of a communication from the examining division (Time limit: M04)
20.07.2016Reply to a communication from the examining division
10.01.2017Despatch of a communication from the examining division (Time limit: M06)
20.07.2017Reply to a communication from the examining division
14.05.2018Cancellation of oral proceeding that was planned for 18.05.2018
17.05.2018Despatch of a communication from the examining division (Time limit: M01)
18.05.2018Date of oral proceedings (cancelled)
27.06.2018Reply to a communication from the examining division
08.01.2019Communication of intention to grant the patent
16.05.2019Fee for grant paid
16.05.2019Fee for publishing/printing paid
16.05.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06848816.2  / EP1959993
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060848816) is  19.09.2011
Opposition(s)03.06.2020No opposition filed within time limit [2020/32]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
05.01.2015Request for further processing filed
05.01.2015Full payment received (date of receipt of payment)
Request granted
23.01.2015Decision despatched
Fees paidRenewal fee
13.09.2013Renewal fee patent year 03
13.09.2013Renewal fee patent year 04
13.09.2013Renewal fee patent year 05
13.09.2013Renewal fee patent year 06
13.09.2013Renewal fee patent year 07
27.12.2013Renewal fee patent year 08
22.12.2014Renewal fee patent year 09
22.12.2015Renewal fee patent year 10
23.12.2016Renewal fee patent year 11
21.12.2017Renewal fee patent year 12
19.12.2018Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.12.2006
AT03.07.2019
CY03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
IE05.12.2019
LU05.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
[2021/32]
Former [2021/26]AT03.07.2019
CY03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
IE05.12.2019
LU05.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
Former [2020/51]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
IE05.12.2019
LU05.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
Former [2020/46]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
IE05.12.2019
LU05.12.2019
Former [2020/39]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
MC03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/37]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SI03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/36]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/25]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
SK03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
PT04.11.2019
IS24.02.2020
Former [2020/24]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
PT04.11.2019
IS24.02.2020
Former [2020/23]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
IT03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
PL03.07.2019
RO03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/22]AT03.07.2019
CZ03.07.2019
DK03.07.2019
EE03.07.2019
ES03.07.2019
FI03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/17]AT03.07.2019
CZ03.07.2019
ES03.07.2019
FI03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
SE03.07.2019
TR03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/12]AT03.07.2019
CZ03.07.2019
ES03.07.2019
FI03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
SE03.07.2019
BG03.10.2019
GR04.10.2019
IS03.11.2019
PT04.11.2019
Former [2020/11]AT03.07.2019
CZ03.07.2019
ES03.07.2019
FI03.07.2019
LT03.07.2019
LV03.07.2019
NL03.07.2019
SE03.07.2019
BG03.10.2019
GR04.10.2019
PT04.11.2019
Former [2020/10]AT03.07.2019
CZ03.07.2019
FI03.07.2019
LT03.07.2019
NL03.07.2019
SE03.07.2019
BG03.10.2019
PT04.11.2019
Former [2020/09]CZ03.07.2019
FI03.07.2019
LT03.07.2019
NL03.07.2019
Former [2020/08]LT03.07.2019
NL03.07.2019
Former [2020/07]NL03.07.2019
Documents cited:Search[Y]US2003232420  (BRAUN ANDREAS [US], et al) [Y] 1-15 * the whole document *;
 [Y]US2003198956  (MAKOWSKI LEE [US], et al) [Y] 1-15 * the whole document *;
 [Y]  - DEYEV S M ET AL, "Design of multivalent complexes using the barnase-barstar module", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20031201), vol. 21, no. 12, ISSN 1087-0156, pages 1486 - 1492, XP002372739 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1038/nbt916
 [A]  - PLUCKTHUN A ET AL, "New protein engineering approaches to multivalent and bispecific antibody fragments", IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, (19970601), vol. 3, no. 2, ISSN 1380-2933, pages 83 - 105, XP004126672 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S1380-2933(97)00067-5
Examination   - ALTO N M ET AL, "Bioinformatic design of A-kinase anchoring protein-in silico: A potent and selective peptide antagonist of type II protein kinase A anchoring", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATIONAL ACADEMY OF SCIENCES, US, (20030415), vol. 100, no. 8, doi:10.1073/PNAS.0330734100, ISSN 0027-8424, pages 4445 - 4450, XP002375233

DOI:   http://dx.doi.org/10.1073/pnas.0330734100
    - NEWLON M G ET AL, "A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, WILEY, DE, (20010101), vol. 20, no. 7, doi:10.1093/EMBOJ/20.7.1651, ISSN 0261-4189, pages 1651 - 1662, XP002978073

DOI:   http://dx.doi.org/10.1093/emboj/20.7.1651
    - F S Kinderman, "A Novel and Dynamic Mechanism for AKAP Binding to RII Isoforms of cAMP-dependent Protein Kinase", Mol Cell, England, doi:10., (20060101), pages 397 - 408, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855097/pdf/nihms14355.pdf, (20181116), XP055524633

DOI:   http://dx.doi.org/10
    - HAUSKEN Z E ET AL, "Mutational analysis of the A-kinase anchoring protein (AKAP)-binding site on RII: Classification of side chain determinants for anchoring and isoform selective association with akaps", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19961115), vol. 271, no. 46, doi:10.1074/JBC.271.46.29016, ISSN 0021-9258, pages 29016 - 29022, XP002375234

DOI:   http://dx.doi.org/10.1074/jbc.271.46.29016
by applicantUS2005002945
 EP0453082
 US6511663
 US5582996
 US4642334
 US4946778
 US5132405
 US6190886
 US5844094
 US5837242
 WO9844001
 US5989830
 US6239259
 US6809185
 US2003232420
 US4624846
 WO9219273
 US2005079184
 US2004018557
 US2003148409
 US2005014207
 US4699784
 US4046722
 US5565215
 US6379698
 US2003082154
 US5620708
 US5702727
 US6530944
 US6306393
 US5021236
 US4472509
 US4824659
 US4932412
 US5525338
 US5716595
 US5736119
 US5922302
 US6096289
 US6387350
 US6331175
 US6077499
 US4863713
 US5256395
 US6090381
 US6472511
 US6962702
 US6126916
 US6010680
 US5776095
 US5776094
 US5776093
 US5772981
 US5753206
 US5746996
 US5697902
 US5328679
 US5128119
 US5101827
 US4735210
 US4331647
 US4348376
 US4361544
 US4468457
 US4444744
 US4460459
 US4460561
 US4818709
 US4671958
 US4046784
 US5332567
 US5443953
 US5541297
 US5601825
 US5635603
 US5637288
 US5677427
 US5686578
 US5698178
 US5789554
 US6187287
 US6319500
 US5798100
 US6132718
 US6440416
 US5734033
 US6458933
 US5223409
 US5622699
 US6068829
 US5582981
 US5595877
 US5637459
 US5475096
 US5270163
 US2004175756
 US2005048512
 US2005053973
 US2005089932
 US2005221384
 US2005025709
 US5169862
 US5539085
 US5576423
 US5051448
 US5559103
 US5889155
 US4036945
 WO0029584
 WO9111465
 US4683195
 US4683202
 US4800159
 US3817837
 US3850752
 US3939350
 US3996345
 US4277437
 US4275149
 US4366241
 US6054495
 US6127120
 US6149868
    - NITTA ET AL., LANCET, (1990), vol. 355, pages 368 - 371
    - KUFER ET AL., TRENDS IN BIOTECHNOL., (2004), vol. 22, pages 238 - 244
    - MACK ET AL., PROC NATL ACAD SCI U.S.A., (1995), vol. 92, pages 7021 - 7025
    - MACK ET AL., J IMMONOL., (1997), vol. 158, pages 3965 - 3970
    - LOFFLER, BLOOD, (2000), vol. 95, pages 2098 - 2103
    - DREIER ET AL., INT J CANCER., (2002), vol. 100, pages 690 - 697
    - DREIER ET AL., J IMMUNOL., (2003), vol. 170, pages 4397 - 4404
    - SCHLERETH ET AL., CANCER RES., (2005), vol. 65, pages 2882 - 2889
    - MILSTEIN; CUELLO, NATURE, (1983), vol. 305, pages 537 - 540
    - STAERZ ET AL., NATURE, (1985), vol. 314, pages 628 - 631
    - PEREZ ET AL., NATURE, (1985), vol. 316, pages 354 - 356
    - STAERZ; BEVAN, PROC NATL ACAD SCI U S A., (1986), vol. 83, pages 1453 - 1457
    - DEMONTE ET AL., PROC NATL ACAD SCI U S A., (1990), vol. 87, pages 2941 - 2945
    - HOLLIGER ET AL., PROC NATL ACAD SCI U S A., (1993), vol. 90, pages 6444 - 6448
    - ATWELL ET AL., MOL IMMUNOL., (1996), vol. 33, pages 1301 - 1302
    - HOLLIGER ET AL., NATURE BIOTECHNOL., (1997), vol. 15, pages 632 - 631
    - HELFRICH ET AL., INT. J CANCER, (1998), vol. 76, pages 232 - 239
    - KIPRIYANOV ET AL., INT J CANCER, (1998), vol. 77, pages 763 - 772
    - HOLLIGER ET AL., CANCER RES., (1999), vol. 59, pages 2909 - 2916
    - COCHLOVIUS ET AL., CANCER RES., (2000), vol. 60, pages 4336 - 4341
    - HOPPE ET AL., FEBS LETTERS, (1994), vol. 344, pages 191 - 195
    - NEWLON ET AL., EMBO J., (2001), vol. 20, pages 1651 - 1662
    - NEWLON ET AL., NATURE, (1999), vol. 3, pages 222 - 227
    - RUSTANDI ET AL., BIOCHEMISTRY, (1998), vol. 37, pages 1951 - 1960
    - ROSE ET AL., NATURE STRUCT BIOL., (2000), vol. 7, pages 744 - 748
    - HODNELAND ET AL., PROC NATL ACD SCI U S A., (2002), vol. 99, pages 5048 - 5052
    - SILVA ET AL., FOOD TECHNOL BIOTECHNOL., (2004), vol. 42, pages 51 - 56
    - FANCY ET AL., CHEM BIOL., (1996), vol. 3, pages 551 - 559
    - BROWN ET AL., BIOCHEMISTRY, (1998), vol. 37, pages 4397 - 4406
    - FANCY; KODADEK, PROC NATL ACAD SCI USA., (1999), vol. 96, pages 6020 - 6024
    - NEBLOCK ET AL., BIOCONJUGATE CHEM., (1991), vol. 3, pages 126 - 31
    - SHARKEY ET AL., INT. J. CANCER, (1992), vol. 51, page 266
    - MIZUKAMI ET AL., NATURE MED., (2005), vol. 11, pages 992 - 97
    - HATFIELD ET AL., CURR. CANCER DRUG TARGETS, (2005), vol. 5, pages 229 - 48
    - VALLBOHMER, J. CLIN. ONCOL., (2005), vol. 23, pages 3536 - 44
    - REN ET AL., ANN. SURG., (2005), vol. 242, pages 55 - 63
    - WALSH ET AL., J BIOL. CHEM., (1968), vol. 243, pages 3763 - 65
    - CORBIN ET AL., J. BIOL. CHEM., (1973), vol. 248, pages 1813 - 21
    - HAUSKEN ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 29016 - 22
    - SCOTT ET AL., J. BIOL. CHEM., (1990), vol. 265, pages 21561 - 66
    - LOHMANN ET AL., PROC. NATL. ACAD. SCI USA., (1984), vol. 81, pages 6723 - 27
    - WONG ET AL., NAT REV MOL CELL BIOL., (2004), vol. 12, pages 959 - 70
    - CARR ET AL., J. BIOL. CHEM., (1991), vol. 266, pages 14188 - 92
    - ALTO ET AL., PROC. NATL. ACAD. SCI USA., (2003), vol. 100, pages 4445 - 50
    - COLLEDGE ET AL., TRENDS CELL BIOL.., (1999), vol. 6, pages 216 - 21
    - BARBAS ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 119
    - WINTER ET AL., ANN. REV. IMMUNOL., (1994), vol. 12, page 433
    - GREEN ET AL., NATURE GENET., (1994), vol. 7, page 13
    - LONBERG ET AL., NATURE, (1994), vol. 368, page 856
    - TAYLOR ET AL., INT. IMMUN., (1994), vol. 6, page 579
    - GILLIES ET AL., J. HNMUNOL. METHODS, (1989), vol. 125, page 191
    - RYSER, PROC. NATL. ACAD. SCI. USA, (1978), vol. 75, pages 3867 - 3870
    - WROBEL; COLLINS, BIOCHIMICA ET BIOPHYSICA ACTA, (1995), vol. 1235, pages 296 - 304
    - LUNDBERG ET AL., J. PHARM. PHARMACOL., (1999), vol. 51, pages 1099 - 1105
    - LUNDBERG ET AL., INT. J. PHARM., (2000), vol. 205, pages 101 - 108
    - LUNDBERG, J. PHARM. SCI., (1994), vol. 83, pages 72 - 75
    - XU ET AL., MOLEC. CANCER THER., (2002), vol. 1, pages 337 - 346
    - TORCHILIN ET AL., PROC. NAT'L. ACAD. SCI., U.S.A., (2003), vol. 100, pages 6039 - 6044
    - WEST ET AL., APPLICATIONS OF NANOTECHNOLOGY TO BIOTECHNOLOGY, (2000), vol. 11, pages 215 - 217
    - BENDAS, BIODRUGS, (2001), vol. 15, pages 215 - 224
    - XU ET AL., MOL. CANCER THER, (2002), vol. 1, pages 337 - 346
    - TORCHILIN ET AL., PROC. NAT'L. ACAD. SCI. U.S.A, (2003), vol. 100, pages 6039 - 6044
    - BALLY ET AL., J. LIPOSOME RES., (1998), vol. 8, pages 299 - 335
    - LUNDBERG, INT. J. PHARM., (1994), vol. 109, pages 73 - 81
    - LUNDBERG, J. PHARM. PHARMACOL., (1997), vol. 49, pages 16 - 21
    - LUNDBERG, ANTI-CANCER DRUG DESIGN, (1998), vol. 13, pages 453 - 461
    - VAN DEN BERGH, CHEM. BRITAIN, (1986), vol. 22, page 430
    - MEW ET AL., J. IMMUNOL, (1983), vol. 130, page 1473
    - CANCER RES., (1985), vol. 45, page 4380
    - OSEROFFET, PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, page 8744
    - PHOTOCHEM. PHOTOBIOL., (1987), vol. 46, page 83
    - HASAN ET AL., PROG. CLIN. BIOL. RES., (1989), vol. 288, page 471
    - TATSUTA ET AL., LASERS SURG. MED., (1989), vol. 9, page 422
    - PELEGRIN ET AL., CANCER, (1991), vol. 67, page 2529
    - NAT BIOTECHNOL., (2005), vol. 23, pages 709 - 717
    - GENE THERAPY, (2006), vol. 13, pages 194 - 195
    - GOVINDAN ET AL., TECHNOLOGY IN CANCER RESEARCH & TREATMENT, (2005), vol. 4, pages 375 - 91
    - SHARKEY; GOLDENBERG, J. NUCL. MED., (2005), vol. 46, pages 115S - 127S
    - GOLDENBERG ET AL., J CLIN ONCOL, (2006), vol. 24, pages 823 - 834
    - SHERWOOD ET AL., BIO/TECHNOLOGY, (1992), vol. 10, page 1446
    - SALTZMAN ET AL., BIOPHYS. J, (1989), vol. 55, page 163
    - PASTAN ET AL., CELL, (1986), vol. 47, page 641
    - GOLDENBERG, CA, A CANCER JOURNAL FOR CLINICIANS, (1994), vol. 44, page 43
    - GEORGAKIS ET AL., BR. J. HAEMATOL., (2005), vol. 130, pages 501 - 510
    - MORI ET AL., FEBS LETT., (2005), vol. 579, pages 5379 - 84
    - GOODWIN ET AL., J. NUCL. MED., (1988), vol. 29, page 226
    - HNATOWICH ET AL., J. NUCL. MED., (1987), vol. 28, page 1294
    - OEHR ET AL., J. NUCL. MED., (1988), vol. 29, page 728
    - KLIBANOV ET AL., J. NUCL. MED., (1988), vol. 29, page 1951
    - SINITSYN ET AL., J. NUCL. MED., (1989), vol. 30, page 66
    - KALOFONOS ET AL., J. NUCL. MED., (1990), vol. 31, page 1791
    - SCHECHTER ET AL., INT. J. CANCER, (1991), vol. 48, page 167
    - PAGANELLI ET AL., CANCER RES., (1991), vol. 51, page 5960
    - PAGANELLI ET AL., NUCL. MED. COMMUN., (1991), vol. 12, page 211
    - STICKNEY ET AL., CANCER RES., (1991), vol. 51, page 6650
    - YUAN ET AL., CANCER RES., (1991), vol. 51, page 3119
    - WAWRZYNCZAK; THORPE, Introduction to the Cellular and Molecular Biology of Cancer, OXFORD UNIVERSITY PRESS, (1986), pages 378 - 410
    - DILLMAN, R. O., CRC Critical Reviews in Oncology/Hematology, CRC PRESS, INC., (1984), vol. 1, page 357
    - VITETTA ET AL., SCIENCE, vol. 238, pages 1098 - 1104
    - BRADY ET AL., INT. J. RAD. ONCOL. BIOL. PHYS., (1987), vol. 13, pages 1535 - 1544
    - GOLDENBERG ET AL., "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radiotherapy", J. CLIN. ONCOL.
    - SHARKEY; GOLDENBERG, J. NUCT..MED., (2005), vol. 46, pages 115S - 127S
    - GOLDENBERG ET AL., "Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy", J. CLIN. ONCOL.
    - ZINSER ET AL., J. EXP MED., (2004), vol. 200, no. 3, pages 345 - 51
    - PALUMBO ET AL., "report that HMBG1 induces mesoangioblast migration and proliferation", J CELL BIOL, (2004), vol. 164, pages 441 - 449
    - YANG ET AL., PNAS USA, (2004), vol. 101, pages 296 - 301
    - KOKKOLA ET AL., ARTHRITIS RHEUM, (2003), vol. 48, pages 2052 - 8
    - CZURA ET AL., J INFECT DIS, (2003), vol. 187, no. 2, pages 391 - 6
    - TREUTIGER ET AL., JLNTERN MED, (2003), vol. 254, pages 375 - 85
    - HUBER-LANG, FASEB J, (2002), vol. 16, pages 1567 - 1574
    - RIEDEMANN, J CLIN INVEST, (2002), vol. 110, pages 101 - 108
    - HANGEN ET AL., J SURG RES, (1989), vol. 46, pages 195 - 199
    - STEVENS ET AL., J CLIN INVEST, (1986), vol. 77, pages 1812 - 1816
    - LO ET AL., BONE MARROW TRANSPLANT, (2002), vol. 30, no. 6, pages 375 - 80
    - BOUROS ET, PMC PULM MED, (2004), vol. 4, no. 1, page 6
    - CHEN ET AL., ARTERIOSCLER THROMB VASC BIOL, (2004), vol. 24, no. 4, pages 709 - 14
    - ULBRICHT ET AL., ARTHRITIS RHEUM, (2004), vol. 50, no. 8, pages 2717 - 8
    - LEIST ET AL., SCIENCE, (2004), vol. 305, no. 5681, pages 164 - 5
    - CUZZOLA ET AL., J IMMUNOL, (2000), vol. 164, pages 5871 - 5876
    - MEDVEDEV ET AL., JLMMUNOL, (1998), vol. 160, pages 4535 - 4542
    - WEYAND; GORONZY, N ENGL JMED, (2003), vol. 349, pages 160 - 169
    - HUNDER; VALENTE, Inflammatory Diseases of Blood Vessels, MARCEL DEKKER, (2002), pages 255 - 265
    - MA-KRUPA ET AL., J EXP MED, (2004), vol. 199, pages 173 - 183
    - GRAMMAR ET AL., J CLIN INVEST, (2003), vol. 112, pages 1506 - 1520
    - KELSOE, J CLIN INVEST, (2003), vol. 112, pages 1480 - 1482
    - KUWANA ET AL., BLOOD, (2004), vol. 103, pages 1229 - 1236
    - COHEN ET AL., ANN RHEUM DIS, (2004), vol. 63, pages 1062 - 8
    - COHEN, RHEUM DIS CLIN NORTH AM, (2004), vol. 30, pages 365 - 80
    - TAYLOR, CURR OPIN PHARMACOL, (2003), vol. 3, pages 323 - 328
    - SMITH; SCOTT, SCIENCE, (1985), vol. 228, pages 1315 - 1317
    - SMITH; SCOTT, METH. ENZYMOL., (1993), vol. 21, pages 228 - 257
    - ARAP ET AL., SCIENCE, (1998), vol. 279, pages 377 - 380
    - PASQUALINI; RUOSLAHTI, NATURE, (1996), vol. 380, pages 364 - 366
    - PASQUALINI, THE QUART. J. NUCL. MED., (1999), vol. 43, pages 159 - 162
    - SILVERMAN ET AL., NAT. BIOTECHNOL., (2005), vol. 23, pages 1493 - 94
    - SILVERMAN ET AL., NAT. BIOTECHNOL., (2006), vol. 24, page 220
    - PRICKETT ET AL., BIOTECHNIQUES, (1989), vol. 7, pages 580 - 589
    - CASTRUCCI ET AL., J VIROL, (1992), vol. 66, pages 4647 - 4653
    - TAM ET AL., J. AM. CHEM. SOC., (1983), vol. 105, page 6442
    - MERRIFIELD, SCIENCE, (1986), vol. 232, pages 341 - 347
    - BARANY; MERRIFIELD, The Peptides, ACADEMIC PRESS, (1979), pages 1 - 284
    - BLONDELLE ET AL., BIOPHYS. J., (1995), vol. 69, pages 604 - 11
    - ECKER; CROOKE, BIOTECHNOLOGY, (1995), vol. 13, pages 351 - 69
    - GOODMAN; RO, BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY, JOHN WILEY & SONS, (1995), vol. I
    - GOODMAN; SHAO, PURE & APPL. CHEM., (1996), vol. 68, pages 1303 - 08
    - HRUBY, LIFE SCI, (1982), vol. 31, pages 189 - 99
    - HOLLADAY ET AL., TETRAHEDRON LETT., (1983), vol. 24, pages 4401 - 04
    - JENNINGS-WHITE ET AL., TETRAHEDRON LETT., (1982), vol. 23, page 2533
    - ALMQUIEST ET AL., J. MED. CHEM., (1980), vol. 23, pages 1392 - 98
    - HUDSON ET AL., INT. J PEPT. RES., (1979), vol. 14, pages 177 - 185
    - SPATOLA ET AL., LIFE SCI, (1986), vol. 38, pages 1243 - 49
    - ZIV ET AL., J. BONE MINER. RES., (1994), vol. 18, no. 2, pages 792 - 94
    - SOLTERO; EKWURIBE, PHARM. TECHNOL., (2001), vol. 6, page 110
    - LOW ET AL., HUM. REPROD., (2005), vol. 20, pages 1805 - 13
    - DUMONT ET AL., J. AEROSOL. MED., (2005), vol. 18, pages 294 - 303
    - NISONOFF ET AL., ARCH. BIOCHEM. BIOPHYS., (1960), vol. 89, page 230
    - PORTER, BIOCHEM. J., (1959), vol. 73, page 119
    - EDELMAN ET AL., METHODS IN ENZYMOLOGY, ACADEMIC PRESS, (1967), page 422
    - INBAR ET AL., PROC. NAT'1. ACAD. SCI. USA, (1972), vol. 69, page 2659
    - SANDHU, CRIT. REV. BIOTECH., (1992), vol. 12, page 437
    - WHITLOW ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 97
    - BIRD ET AL., SCIENCE, (1988), vol. 242, page 423
    - PACK ET AL., BIO/TECHNOLOGY, (1993), vol. 11, page 1271
    - LARRICK ET AL., METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, (1991), vol. 2, page 106
    - RITTER ET AL., MONOCLONAL ANTIBODIES: PRODUCTION, ENGINEERING AND CLINICAL APPLICATION, CAMBRIDGE UNIVERSITY PRESS, (1995), pages 166 - 179
    - BIRCH ET AL.,, MONOCLONAL ANTIBODIES: PRINCIPLES AND APPLICATIONS, WILEY-LISS, INC., (1995), pages 137 - 185
    - LEUNG ET AL., HYBRIDOMA, (1994), vol. 13, page 469
    - JONES ET AL., NATURE, (1986), vol. 321, page 522
    - RIECHMANN ET AL., NATURE, (1988), vol. 332, page 323
    - VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, page 1534
    - CARTER ET AL., PROC. NAT'L ACAD. SCI. USA, (1992), vol. 89, page 4285
    - TEMPEST ET AL., BIOTECHNOLOGY, (1991), vol. 9, page 266
    - SINGER ET AL., J. MUMMOL., (1993), vol. 150, page 2844
    - LOSMAN ET AL., INT. J. CANCER, (1990), vol. 46, page 310
    - MANCINI ET AL., NEW MICROBIOL., (2004), vol. 27, pages 315 - 28
    - CONRAD; SCHELLER, COMB. CHEM. HIGH THROUGHPUT SCREEN., (2005), vol. 8, pages 117 - 26
    - BREKKE; LOSET, CURR. OPIN. PHAMACOL., (2003), vol. 3, pages 544 - 50
    - DANTAS-BARBOSA ET AL., GENET. MOL. RES., (2005), vol. 4, pages 126 - 40
    - MARKS ET AL., J. MOL. BIOL., (1991), vol. 222, pages 581 - 97
    - ANDRIS-WIDHOPF ET AL., Phage Display Laboratory Manual, COLD SPRING HARBOR LABORATORY PRESS, (2000), pages 9.1 - 9.22
    - GREEN ET AL., J. IMMUNOL. METHODS, (1999), vol. 231, pages 11 - 23
    - "Cell Marking Techniques and Their Application", PONDER, MAMMALIAN DEVELOPMENT: A PRACTICAL APPROACH, IRL PRESS, (1987), vol. 113-38, pages 5.8.1 - 5.8.8
    - KENNEDY ET AL., CLIN. CHIM. ACTA, (1976), vol. 70, page 1
    - SCHURS ET AL., CLIN. CHIM. ACTA, (1977), vol. 81, page 1
    - SHIH ET AL., INT'L J. CANCER, (1990), vol. 46, page 1101
    - "Medical Applications of Radioisotopes", CHASE ET AL., REMINGTON'S PHARMACEUTICAL SCIENCES, MACK PUBLISHING CO., (1990), pages 624 - 652
    - "Clinical Use of Monoclonal Antibodies", BROWN ET AL., BIOTECHNOLOGY AND PHARMACY, CHAPMAN & HALL, (1993), pages 227 - 49
    - GOLDENBERG ET AL., "Antibody Pre-targeting Advances Cancer Radioimmunodetection and Radioimmunotherapy", J CLIN ONCOL, (2006), vol. 24, pages 823 - 834
    - LEE; MEISEL, J. PHYS. CHEM., (1982), vol. 86, pages 3391 - 3395
    - GILLIES ET AL., J IMMUNOL METHODS, (1989), vol. 125, pages 191 - 202
    - LOSMAN ET AL., CANCER (PHILA, (1997), vol. 80, pages 2660 - 6
    - ALTO ET AL., PROC. NATL. ACAD. SCI., U.S.A, (2003), vol. 100, pages 4445 - 50
    - LE DOUSSAL ET AL., J NUCL MED, (1989), vol. 30, pages 1358 - 66
    - ROSSI ET AL., CLIN CANCER RES., (2005), vol. 11, no. 19, pages 7122S - 7129S
    - DOHERTY ET AL., BIOCONJUGATE CHEM., (2005), vol. 16, pages 1291 - 1298
    - CWIRTA ET AL., SCIENCE, (1997), vol. 276, pages 1696 - 1699
    - SHIH ET AL., "conjugation of anthracyclin to amino-dextran", CANCER RES., (1991), vol. 51, pages 4192 - 4198
    - TACKEN ET AL., J. IMMUNOL., (2004), vol. 172, pages 4934 - 4940
    - BROKX ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 2327 - 2332
    - ROSSI ET AL., PROC NATL ACAD SCI USA., (2006), vol. 103, no. 18, pages 6841 - 6
 US20050296432
 US20030350096
 US20010921290
 US20010342104
 US20030361026
 US19990337756
 US20010823746
 US20020116116
 US19990382186
 US20020150654
 US20020114315
 US20020386411
 US20020345641
 US20010328835
 US20020426379
 US20010342103
 US20040634076
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.